Daniel Karlin Receives Stock Award at Definium Therapeutics Inc (DFTX) — SEC Form 4, Aug 12, 2026

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Daniel Karlin

Officer

TXN 2026-08-12 · FILED 2026-08-12

Equity Position 603K sh 503,282 → 603,282

Equity Change +19.9% shares held after vs before

Filing Lag 0 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Definium Therapeutics Inc

DFTX CIK 0001813814

Reporting Owner

Name	Relationship
Daniel Karlin CIK 0001897618	Officer

Daniel Karlin at Definium Therapeutics Inc Full insider history

Bought (12 mo) —

Sold (12 mo) $1,070,485

More from this insider at Definium Therapeutics Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common SharesF1	2026-08-12	A - Award/Grant	100,000 A	$0.00	—	603,282	Direct

Footnotes (1)

F1: The common shares represent the second tranche of performance share units granted effective March 12, 2025, and remain subject to vesting based on the Reporting Person's continued employment through March 12, 2028. Each performance share unit represented a contingent right to receive one common share based on, and subject to, the achievement of certain clinical and regulatory milestones set forth in the Performance Share Unit Award Agreement. Show more

5%+ Holders · 13D/G 4 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Definium Therapeutics Inc

GET /v1/forms/4/0001193125-26-345838 API docs